167 related articles for article (PubMed ID: 21053849)
1. Pharmacogenomic considerations for customizing warfarin therapy in the orthopedic patient.
Rhee S; Walsh K; Lewis D; Davis G; Smith KM
Orthopedics; 2010 Nov; 33(11):828. PubMed ID: 21053849
[No Abstract] [Full Text] [Related]
2. Refining the use of warfarin through genetic testing.
Lee SC
Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287
[No Abstract] [Full Text] [Related]
3. Dynamic pharmacogenetic models in anticoagulation therapy.
Bon Homme M; Reynolds KK; Valdes R; Linder MW
Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061
[TBL] [Abstract][Full Text] [Related]
4. Using genetic testing to guide warfarin therapy.
Ungerer LL; Pestka EL; Messner PK
Nursing; 2012 May; 42(5):63-5. PubMed ID: 22531080
[No Abstract] [Full Text] [Related]
5. Warfarin pharmacogenetics: ready for clinical utility?
Baudhuin LM
Clin Lab Sci; 2009; 22(3):151-5. PubMed ID: 19827409
[No Abstract] [Full Text] [Related]
6. Pharmacogenetic-based dosing of warfarin.
Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
[No Abstract] [Full Text] [Related]
7. The long and winding road to warfarin pharmacogenetic testing.
Ginsburg GS; Voora D
J Am Coll Cardiol; 2010 Jun; 55(25):2813-5. PubMed ID: 20579536
[No Abstract] [Full Text] [Related]
8. Pharmacogenomic testing for warfarin dosing: we are ready now.
Wu AH
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1483-5. PubMed ID: 19954308
[No Abstract] [Full Text] [Related]
9. Warfarin and pharmacogenomic testing: what would Pascal do?
Teagarden JR
Pharmacotherapy; 2009 Mar; 29(3):245-7. PubMed ID: 19249943
[No Abstract] [Full Text] [Related]
10. Pathology consultation on warfarin pharmacogenetic testing.
Stack G;
Am J Clin Pathol; 2011 Jan; 135(1):13-9. PubMed ID: 21173120
[No Abstract] [Full Text] [Related]
11. [Pharmacogenetics of indirect anticoagulants: value of genotype for improvement of efficacy and safety of therapy].
Sychov DA; Kropacheva ES; Ignat'ev IV; Bulytova IuM; Dobrovol'skiĭ AB; Panchenko EP; Kukes VG
Kardiologiia; 2006; 46(7):72-7. PubMed ID: 16883270
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
Schwarz UI; Stein CM
Clin Pharmacol Ther; 2006 Jul; 80(1):7-12. PubMed ID: 16815312
[No Abstract] [Full Text] [Related]
13. Genetic testing for warfarin dosing? Not yet ready for prime time.
Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
[No Abstract] [Full Text] [Related]
14. Prediction of warfarin dose: why, when and how?
Eriksson N; Wadelius M
Pharmacogenomics; 2012 Mar; 13(4):429-40. PubMed ID: 22379999
[TBL] [Abstract][Full Text] [Related]
15. Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.
Mannucci PM; Spreafico M; Peyvandi F
J Thromb Haemost; 2008 Sep; 6(9):1450-2. PubMed ID: 18627441
[No Abstract] [Full Text] [Related]
16. Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.
Siguret V; Pautas E; Gouin-Thibault I
Vitam Horm; 2008; 78():247-64. PubMed ID: 18374198
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics of warfarin].
Kessler P
Vnitr Lek; 2006 Mar; 52 Suppl 1():31-4. PubMed ID: 16637447
[TBL] [Abstract][Full Text] [Related]
18. Genotype and adverse drug reactions to warfarin.
Byron KA; Dear AE
Med J Aust; 2007 Jul; 187(1):61-2. PubMed ID: 17605718
[No Abstract] [Full Text] [Related]
19. Q: Should we use pharmacogenetic testing when prescribing warfarin?
Rouse M; Cristiani C; Teng KA
Cleve Clin J Med; 2013 Aug; 80(8):483-6. PubMed ID: 23908104
[No Abstract] [Full Text] [Related]
20. Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.
King CR; Porche-Sorbet RM; Gage BF; Ridker PM; Renaud Y; Phillips MS; Eby C
Am J Clin Pathol; 2008 Jun; 129(6):876-83. PubMed ID: 18480003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
